Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03558503 |
|---|---|
| Brief Title: | The Efficacy and Safety of UGN-102 as a Primary Chemoablative Therapy in Patients With LG NMIBC at Intermediate Risk of Recurrence |
| First Submitted : | May 8, 2018 |
| First Submitted that Met QC Criteria : | June 3, 2018 |
| First Posted : | June 15, 2018 |
| Last Update Submitted that Met QC Criteria : | January 15, 2020 |
| Last Update Posted : | January 18, 2020 |